BioMarin’s March 20 $70 Put Implied Volatility Spikes to Top Tier
BioMarin’s March 20, 2026 $70 put showed one of the highest implied volatilities among equity options, indicating traders expect a significant stock swing. Analysts have cut the current-quarter EPS consensus from $1.29 to $1.16 over the past 60 days, leaving BioMarin at a Zacks Rank #3.
1. Surge in Put Implied Volatility
The March 20, 2026 $70 put on BioMarin posted one of the highest implied volatilities among all equity options, signaling that traders are bracing for a large directional move in the company’s share price ahead of expiration.
2. Analyst EPS Estimate Revisions
Over the past 60 days, three analysts have adjusted their current-quarter earnings forecasts for BioMarin, lowering the consensus EPS estimate from $1.29 to $1.16 per share and maintaining a hold rating in the mid-tier of its industry.
3. Premium Selling Strategies Considered
High implied volatility on the $70 put may encourage experienced options traders to sell premium, aiming to capture time decay under the expectation that BioMarin’s actual price movement will be narrower than the market’s current projections.